Clinical Trials Logo

Filter by:
NCT ID: NCT05938062 Completed - Placenta Accreta Clinical Trials

Fibrinogen Concentrate and Placenta Acreta Spectrum

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the relationship between fibrinogen use and bleeding in patients who underwent cesarean section with a prediagnosis of PAS. The key question(s) it aims to answer are: [Does the use of fibrinogen concentrate reduce bleeding in PAS patients?] Patients who had a cesarean section with a pre-diagnosis of PAS were analyzed retrospectively. The choice of anesthesia applied to the patients and the relationship between the use of blood products and bleeding were evaluated.

NCT ID: NCT05938023 Active, not recruiting - Clinical trials for Duchenne Muscular Dystrophy

A Study of ATL1102 or Placebo in Participants With Non-ambulatory Duchenne Muscular Dystrophy

Start date: May 18, 2023
Phase: Phase 2
Study type: Interventional

This Phase IIb study is a two part, multicenter study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of ATL1102 in non-ambulant boys with Duchenne Muscular Dystrophy aged 10 to <18 years old. The study includes a randomised, double-blind, placebo-controlled treatment period (Part A), followed by an open labelled treatment period (Part B).

NCT ID: NCT05937971 Recruiting - Multiple Sclerosis Clinical Trials

Plantar Sensitivity Training and Aerobic Exercise Training in Patients With Multiple Sclerosis (PlaSTAcET Study)

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

The aim of this thesis study is to examine whether plantar sensory training given in addition to aerobic exercise training has an additional contribution to balance, functional capacity, walking and proprioception in patients with multiple sclerosis. In this direction, the hypotheses of the study are stated below. H0 hypothesis: Plantar sensory training given in addition to aerobic exercise training in patients with multiple sclerosis has no additional contribution to balance, functional capacity, walking and proprioception. H1 hypothesis: Plantar sensory training given in addition to aerobic exercise training in patients with multiple sclerosis has an additional contribution to balance, functional capacity, walking and proprioception. Conventional exercises (with the addition of warm-up and cool-down periods) will be applied to all multiple sclerosis patients participating in the study; In addition, aerobic exercise training will be given. In addition to these exercises, plantar sensory training will be given to the sensory training group. Exercises and plantar sensory training will be given to the participants at intervals of three weeks, with progressively progressive sessions, 2 days a week for 12 weeks. Patients will be evaluated twice, before treatment and at the end of treatment 12 weeks later. Within the scope of the evaluation, balance, functional capacity, gait, proprioception and plantar sensory parameters will be measured in patients. As a result of the study, it will be examined whether plantar sensory training given in addition to aerobic exercise training in multiple sclerosis patients has an additional contribution to balance, functional capacity, walking and proprioception. There is no study in the literature examining the effects of plantar sensory training and aerobic exercise training on balance, functional capacity, walking and proprioception in patients with multiple sclerosis. In this respect, it is anticipated that the study will contribute to the literature.

NCT ID: NCT05937737 Completed - Type 2 Diabetes Clinical Trials

Serum FGF21 Levels and Dietary Total Antioxidant Capacity in Type 2 Diabetes

Start date: April 20, 2020
Phase: N/A
Study type: Interventional

This study aimed to evaluate the phytochemicals and total antioxidant capacity in the diets of individuals with type 2 diabetes and assess their relationship with glycemic parameters, as well as certain biochemical parameters and Fibroblast growth factor 21 (FGF21), which is an inflammatory marker. The study was conducted on a total of 80 individuals, including 40 patients with overweight or obesity (Body Mass Index (BMI) > 25 kg/m²) with type 2 diabetes aged between 18 and 64, and 40 healthy controls (BMI between 18.5-35 kg/m²). The individuals were followed for 12 weeks with an appropriate diet. Biochemical parameters, anthropometric measurements, and dietary intake records were monitored at specific intervals throughout the study. The phytochemical index and total antioxidant capacity of the individuals' diets were measured, and FGF21 was examined in the serum.

NCT ID: NCT05937711 Completed - Fibromyalgia Clinical Trials

The Effect of Transcutaneous Posterior Tibial Nerve Stimulation in Patients With Fibromyalgia

Start date: November 2, 2020
Phase: N/A
Study type: Interventional

This study aimed to investigate the effectiveness of posterior tibial nerve stimulation (PTNS) in reducing pain, improving quality of life, and decreasing disease severity in patients with fibromyalgia.

NCT ID: NCT05937607 Enrolling by invitation - Hand Massage Clinical Trials

The Effect of the Hand Massage A Women Undergoing Brachytherapy

Start date: June 14, 2023
Phase: N/A
Study type: Interventional

Background Gynecologic cancers are among the ten most common cancers among women. During brachytherapy, women can have pain and situational anxiety due to the treatment. Methods This parallel-group randomized controlled study evaluated the effect of the hand massage practiced using baby oil, with lavender oil, on reducing operational pain and situational anxiety in women with brachytherapy. The study was completed with 36 patients. The treatment group included 18 patients, and the control group had 18. The data were collected through patient information form, visual analog scale, and state anxiety inventory. Before the brachytherapy, three sessions of hand massages, each lasting 10 minutes (5 minutes for each hand), were performed using baby oil with lavender. Data collection forms were repeated after each session. The control group received routine treatment. p<0.05 was accepted as significant.

NCT ID: NCT05937516 Completed - Epistaxis Nosebleed Clinical Trials

Guidewire Use in Nasotracheal Intubation

Start date: March 15, 2023
Phase: N/A
Study type: Interventional

During nasotracheal intubation, nasopharyngeal trauma and associated bleeding may occur. The investigators think that some of this bleeding is due to trauma to the posterior wall of the nasopharynx. The investigators designed this study, thinking that if nasopharyngeal posterior wall trauma can be prevented, some of these bleedings can be prevented.

NCT ID: NCT05937503 Not yet recruiting - Manual Therapy Clinical Trials

Efficiency of Manual Therapy on Central Sensitization in Patients With Nonspecific Chronic Back Pain

Start date: July 17, 2023
Phase: N/A
Study type: Interventional

Central sensitization (CS) is defined as the increased responsiveness of nociceptive neurons in the central nervous system to normal or subthreshold afferent input. CS has been proposed as an underlying mechanism of chronic pain in musculoskeletal disorders including low back pain (LBP). The aim of this study is to investigate the effect of manual therapy on central sensitization in patients with nonspecific chronic LBP.

NCT ID: NCT05937464 Completed - Clinical trials for Stroke, Robotic Rehabilitation

Effects of Robotic-Assisted Gait Training in Patients With Stroke (EoRAGTiPwS)

EoRAGTiPwS
Start date: June 1, 2021
Phase: N/A
Study type: Interventional

This study was conducted to examine effects of gait training with exoskeleton ExoAthlet and Lokomat Free-D on functional independence, functional capacity and quality of life in stroke patients.

NCT ID: NCT05936983 Completed - Schizophrenia Clinical Trials

Comparison of Physical Fitness, Physical Activity Level in Patients With Bipolar Disorder and Schizophrenia

Start date: June 2, 2023
Phase:
Study type: Observational

According to the World Health Organization; Bipolar disorder ranks in the top 20 causes of disability among all medical conditions and 6th among mental disorders worldwide. Bipolar disorder is noted as a serious mental illness involving emotional ups and downs.